Figure S6 from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Qazi, Maleeha; Vora, Parvez; Venugopal, Chitra; Adams, Jarrett; Singh, Mohini; Hu, Amy; Gorelik, Maryna; Subapanditha, Minomi; Savage, Neil; Yang, Jiahe; Chokshi, Chirayu; London, Max; Gont, Alexander; Bobrowski, David; Grinshtein, Natalie; Brown, Kevin R.; Murty, Naresh K.; Nilvebrant, Johan; Kaplan, David L.; Moffat, Jason; Sidhu, Sachdev S.; Singh, Sheila K.

doi:10.1158/0008-5472.22425568

2023

DOI: 10.1158/0008-5472.22425568

|View full text |Cite

Preprint

Figure S6 from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Maleeha Qazi¹,

Parvez Vora²,

Chitra Venugopal³

et al.

Abstract: <p>EphA2/A3 BsAb also targets EphA2+/EphA3- and EphA2-/EphA3+ cell populations, does not affect cell cycle or apoptosis, and leads to increased expression of GFAP and MAP2.</p>

Help me understand this report

View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Figure S6 from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Abstract: <p>EphA2/A3 BsAb also targets EphA2+/EphA3- and EphA2-/EphA3+ cell populations, does not affect cell cycle or apoptosis, and leads to increased expression of GFAP and MAP2.</p>

This publication either has no citations yet, or we are still processing them

See others like this or search for similar articles

Contact Info

Product

Resources

About